aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results

February 28, 2024

https://www.globenewswire.com/news-release/2024/02/28/2836889/0/en/aTyr-Pharma-to-Webcast-Conference-Call-Reporting-Fourth-Quarter-and-Full-Year-End-2023-Financial-Results.html

SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq:LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that it will report fourth quarter and full year 2023 financial results and provide a corporate update after the market close on Thursday, March 14, 2024. Management will host a conference call and webcast to review the results and provide an operational update.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.